![Paul Low](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Paul Low
Private Equity Investor bij New World Health LLC
Profiel
Paul Low is currently the Managing Partner at New World Health LLC.
He previously worked as a Principal at Shire Regenerative Medicine, Inc., Advantasure, Inc., and HZNP USA LLC.
Actieve functies van Paul Low
Bedrijven | Functie | Begin |
---|---|---|
New World Health LLC
![]() New World Health LLC Investment ManagersFinance New World Health LLC (New World Health) is a venture capital firm founded in 2015. The firm is headquartered in New York. | Private Equity Investor | - |
Eerdere bekende functies van Paul Low
Bedrijven | Functie | Einde |
---|---|---|
Advantasure, Inc.
![]() Advantasure, Inc. Miscellaneous Commercial ServicesCommercial Services Advantasure, Inc. provides management services for the healthcare industry. Its offers traditional administrative services such as bookkeeping, human resources management, and non-professional staffing; medical information systems; data mining and control; and physician risk management. The company was founded by Eric D. Moskow in 2011 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Shire Regenerative Medicine, Inc.
![]() Shire Regenerative Medicine, Inc. BiotechnologyHealth Technology Shire Regenerative Medicine, Inc. develops and commercializes living cell therapies. It manufactures and markets dermagraft, a bio-engineered skin substitute that assists in restoring damaged tissue and supports the body's natural healing process. The company was founded in 2004 and is headquartered in Westport, CT. | Corporate Officer/Principal | - |
HZNP USA LLC
![]() HZNP USA LLC Pharmaceuticals: MajorHealth Technology HZNP USA LLC acquires, develops, markets and distributes specialty pharmaceutical products. The firm offers Actimmune, which is a bioengineered form of interferon gamma-1b, a protein that acts as a biologic response modifier through stimulation of the human immune system. Its Actimmune product is used for reducing the frequency and severity of serious infections related to chronic granulomatous diseases, and for delaying time to disease progression in patients with severe malignant osteopetrosis. The company was founded in 2011 by Balaji K. Venkataraman and Virinder Nohria and is headquartered in Lake Forest, FL. | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 4 |
---|---|
New World Health LLC
![]() New World Health LLC Investment ManagersFinance New World Health LLC (New World Health) is a venture capital firm founded in 2015. The firm is headquartered in New York. | Finance |
HZNP USA LLC
![]() HZNP USA LLC Pharmaceuticals: MajorHealth Technology HZNP USA LLC acquires, develops, markets and distributes specialty pharmaceutical products. The firm offers Actimmune, which is a bioengineered form of interferon gamma-1b, a protein that acts as a biologic response modifier through stimulation of the human immune system. Its Actimmune product is used for reducing the frequency and severity of serious infections related to chronic granulomatous diseases, and for delaying time to disease progression in patients with severe malignant osteopetrosis. The company was founded in 2011 by Balaji K. Venkataraman and Virinder Nohria and is headquartered in Lake Forest, FL. | Health Technology |
Advantasure, Inc.
![]() Advantasure, Inc. Miscellaneous Commercial ServicesCommercial Services Advantasure, Inc. provides management services for the healthcare industry. Its offers traditional administrative services such as bookkeeping, human resources management, and non-professional staffing; medical information systems; data mining and control; and physician risk management. The company was founded by Eric D. Moskow in 2011 and is headquartered in New York, NY. | Commercial Services |
Shire Regenerative Medicine, Inc.
![]() Shire Regenerative Medicine, Inc. BiotechnologyHealth Technology Shire Regenerative Medicine, Inc. develops and commercializes living cell therapies. It manufactures and markets dermagraft, a bio-engineered skin substitute that assists in restoring damaged tissue and supports the body's natural healing process. The company was founded in 2004 and is headquartered in Westport, CT. | Health Technology |